Literature DB >> 34299162

IgA Vasculitis: Etiology, Treatment, Biomarkers and Epigenetic Changes.

Hitomi Sugino1, Yu Sawada1, Motonobu Nakamura1.   

Abstract

IgA, previously called Henoch-Schönlein vasculitis, is an essential immune component that drives the host immune response to the external environment. As IgA has the unique characteristic of a flexible response to broad types of microorganisms, it sometimes causes an autoreactive response in the host human body. IgA vasculitis and related organ dysfunction are representative IgA-mediated autoimmune diseases; bacterial and viral infections often trigger IgA vasculitis. Recent drug developments and the presence of COVID-19 have revealed that these agents can also trigger IgA vasculitis. These findings provide a novel understanding of the pathogenesis of IgA vasculitis. In this review, we focus on the characteristics of IgA and symptoms of IgA vasculitis and other organ dysfunction. We also mention the therapeutic approach, biomarkers, novel triggers for IgA vasculitis, and epigenetic modifications in patients with IgA vasculitis.

Entities:  

Keywords:  IgA vasculitis; biomarker; epigenetic changes; treatment

Year:  2021        PMID: 34299162     DOI: 10.3390/ijms22147538

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  9 in total

1.  Navigating the initial diagnosis and management of adult IgA vasculitis: A review.

Authors:  Brenna G Kelly; Delaney B Stratton; Iyad Mansour; Bekir Tanriover; Keliegh S Culpepper; Clara Curiel-Lewandrowski
Journal:  JAAD Int       Date:  2022-06-13

2.  A case of pathologically confirmed streptococcal infection-related IgA vasculitis with associated glomerulonephritis and leukocytoclastic cutaneous vasculitis.

Authors:  Taichi Inoue; Kazuhiro Takeuchi; Arimi Ishikawa; Mika Terasaki; Yutaka Arai; Saeko Hatanaka; Yoshitaka Hirano; Shun Miyazaki; Toshihiko Hoashi; Akiko Mii; Hidehisa Saeki; Yukinao Sakai; Akira Shimizu
Journal:  CEN Case Rep       Date:  2022-02-14

3.  COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports.

Authors:  Assylzhan Messova; Lyudmila Pivina; Zhanna Muzdubayeva; Didar Sanbayev; Zhanar Urazalina; Amber Adams
Journal:  J Emerg Nurs       Date:  2022-05-13       Impact factor: 2.303

4.  Urinary Protein Array Analysis to Identify Key Inflammatory Markers in Children with IgA Vasculitis Nephritis.

Authors:  Julien Marro; Andrew J Chetwynd; Rachael D Wright; Silothabo Dliso; Louise Oni
Journal:  Children (Basel)       Date:  2022-04-27

Review 5.  Epigenetic Modification of PD-1/PD-L1-Mediated Cancer Immunotherapy against Melanoma.

Authors:  Hikaru Nanamori; Yu Sawada
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 6.  [Update on immunoglobulin A vasculitis].

Authors:  Thomas Neumann
Journal:  Z Rheumatol       Date:  2022-03-18       Impact factor: 1.372

7.  Immunoglobulin A vasculitis induced by atypical pneumonia infection with Chlamydophila pneumonia.

Authors:  Seung Ah Kang; Suha Abu Khalaf; Taylor Nelson
Journal:  IDCases       Date:  2022-09-26

8.  Paraneoplastic IgA Vasculitis in an Older Adult With Metastatic Lung Adenocarcinoma.

Authors:  Khashayar Farzam; Harris Syed
Journal:  Cureus       Date:  2021-09-08

Review 9.  The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review.

Authors:  Hareem Farooq; Muhammad Aemaz Ur Rehman; Abyaz Asmar; Salman Asif; Aliza Mushtaq; Muhammad Ahmad Qureshi
Journal:  J Taibah Univ Med Sci       Date:  2021-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.